- $20.91bn
- $20.39bn
- $6.36bn
- 93
- 37
- 97
- 88
2019 April 26th | 2020 April 24th | 2021 April 30th | 2022 April 29th | 2023 April 28th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,146 | 5,412 | 5,744 | 6,318 | 6,362 |
Cost of Revenue | |||||
Gross Profit | 3,945 | 3,623 | 3,815 | 4,220 | 4,209 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,925 | 4,477 | 4,727 | 5,161 | 5,344 |
Operating Profit | 1,221 | 935 | 1,017 | 1,157 | 1,018 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,268 | 944 | 962 | 1,095 | 1,066 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,169 | 819 | 730 | 937 | 1,274 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,169 | 819 | 730 | 937 | 1,274 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,169 | 819 | 730 | 937 | 1,274 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.38 | 3.5 | 2.96 | 4.26 | 6.22 |
Dividends per Share |